The board of directors of Yues International Holdings Group Limited announced that with effect from 9 December 2023, Mr. Li Zhigang (Mr. Li') has been appointed as an executive Director. Mr. Li, aged 41, is currently the executive director and general manager of Suzhou Institute of Traditional Chinese Medicine Co. Ltd. and a director of Jiangsu Kangda Testing Technology Co.

Ltd. Mr. Li has served as an external tutor at Xi'an Jiaotong-Liverpool University since September 2021. Mr. Li worked in various positions at Suzhou Yuanchuang Pharmaceutical Research Co. Ltd., Suzhou Youseen New Drug Development Co.

Ltd., and ReneSola Ltd. (now known as Emeren Group Ltd). Mr. Li passed the National Unified Legal Professional Qualification Examination of the People's Republic of China (the PRC') in April 2021. Mr. Li is an non-practicing member of Shanghai Institute of Certified Public Accountants, a registered tax agent in the PRC, a certified internal auditor of the Institute of Internal Auditors and obtained the certification in risk management assurance from the Institute of Internal Auditors.

He obtained a bachelor's degree in engineering with major in biological engineering from Wuhan Technical Institute (now known as Wuhan Polytechnic University) in June 2003 and a master's degree in business administration from Xi'an Jiaotong University in June 2017. The board announced that Mr. Song Ruipeng (Mr. Song') has been removed as an executive Director with effect from 9 December 2023 by notice in writing served on him signed by not less than three-fourths in number (or if that is not a round number, the nearest lower round number) of the Directors (including Mr. Song) then in office in accordance with article 105 (h) of the articles of association of the Company having considered Mr. Song's failure to discharge his duties and responsibilities in the capacity as an executive Director.